| Entertainment Medical Group Inc | |
|
8920 Wilshire Blvd Ste 330 Beverly Hills CA 90211-2011 | |
| (323) 954-8084 | |
| (323) 587-9429 |
| Full Name | Entertainment Medical Group Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 8920 Wilshire Blvd Ste 330, Beverly Hills, California |
| Authorized Official Name and Position | Adam David Karns (PRESIDENT) |
| Authorized Official Contact | 3239548084 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Entertainment Medical Group Inc 8920 Wilshire Blvd Ste 330 Beverly Hills CA 90211-2011 Ph: (323) 954-8084 | Entertainment Medical Group Inc 8920 Wilshire Blvd Ste 330 Beverly Hills CA 90211-2011 Ph: (323) 954-8084 |
| NPI Number | 1710273636 |
|---|---|
| Provider Enumeration Date | 06/20/2011 |
| Last Update Date | 09/01/2023 |
| Medicare PECOS PAC ID | 1850556622 |
|---|---|
| Medicare Enrollment ID | O20120628000278 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the release of the HCA ImagAmp reagent kit for high content screening and analysis applications in life sciences and drug discovery research.
A study led by scientists at the Walter Reed Army Institute of Research sheds new light on the body's initial response to dengue virus (DENV) infection, describing the molecular diversity and specificity of the antibody response.
Scientists at The Scripps Research Institute and collaborating institutions have described the first-ever immature or "teenage" antibody found in a powerful class of immune molecules effective against HIV.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that the European Commission has granted orphan medicinal product designation for RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21") for the treatment of Alport syndrome, a life-threatening genetic kidney disease with no approved therapy.
Gen-Probe Incorporated announced today that the Company has submitted a Premarket Approval Application (PMA) to the US Food and Drug Administration (FDA) for its APTIMA® HPV (human papillomavirus) assay, a new molecular test that detects high-risk HPV infections that are associated with cervical cancer and precancerous lesions.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710273636 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | G74846 (California) | Primary |
| Provider Name | Adam D Karns |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1811979198 PECOS PAC ID: 8820267545 Enrollment ID: I20110812000533 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the release of the HCA ImagAmp reagent kit for high content screening and analysis applications in life sciences and drug discovery research.
A study led by scientists at the Walter Reed Army Institute of Research sheds new light on the body's initial response to dengue virus (DENV) infection, describing the molecular diversity and specificity of the antibody response.
Scientists at The Scripps Research Institute and collaborating institutions have described the first-ever immature or "teenage" antibody found in a powerful class of immune molecules effective against HIV.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that the European Commission has granted orphan medicinal product designation for RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21") for the treatment of Alport syndrome, a life-threatening genetic kidney disease with no approved therapy.
Gen-Probe Incorporated announced today that the Company has submitted a Premarket Approval Application (PMA) to the US Food and Drug Administration (FDA) for its APTIMA® HPV (human papillomavirus) assay, a new molecular test that detects high-risk HPV infections that are associated with cervical cancer and precancerous lesions.
› Verified 2 days ago
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the release of the HCA ImagAmp reagent kit for high content screening and analysis applications in life sciences and drug discovery research.
A study led by scientists at the Walter Reed Army Institute of Research sheds new light on the body's initial response to dengue virus (DENV) infection, describing the molecular diversity and specificity of the antibody response.
Scientists at The Scripps Research Institute and collaborating institutions have described the first-ever immature or "teenage" antibody found in a powerful class of immune molecules effective against HIV.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that the European Commission has granted orphan medicinal product designation for RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21") for the treatment of Alport syndrome, a life-threatening genetic kidney disease with no approved therapy.
Gen-Probe Incorporated announced today that the Company has submitted a Premarket Approval Application (PMA) to the US Food and Drug Administration (FDA) for its APTIMA® HPV (human papillomavirus) assay, a new molecular test that detects high-risk HPV infections that are associated with cervical cancer and precancerous lesions.
› Verified 2 days ago
Treatmedngo Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8950 W Olympic Blvd Ste 103&104, Beverly Hills, CA 90211 Phone: 310-274-8080 | |
Refael Medical, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8200 Wilshire Blvd, Beverly Hills, CA 90211 Phone: 310-879-7167 Fax: 310-933-5688 | |
Michael D. Borookhim, M.d., Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9301 Wilshire Blvd, Suite 602, Beverly Hills, CA 90210 Phone: 310-288-0881 | |
Ultrasound Specialists Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9001 Wilshire Blvd, Suite 106, Beverly Hills, CA 90211 Phone: 310-273-8885 | |
Kaiser Permanente Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 204 S Arnaz Dr Apt 3, Beverly Hills, CA 90211 Phone: 213-215-5142 | |
Nancy P. Rahnama, M.d., A.p.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 421 N Rodeo Dr, Penthouse Number 1, Beverly Hills, CA 90210 Phone: 310-299-7373 Fax: 310-432-6647 | |
Laurence Seigler, M.d. Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 435 N Bedford Dr, Suite 308, Beverly Hills, CA 90210 Phone: 310-274-6158 Fax: 310-274-5709 |